Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin

This publication has 34 references indexed in Scilit:

• The Erythropoietin Receptor: Structure, Activation and Intracellular Signal Transduction
  Trends in Endocrinology & Metabolism, 1999
• Epoetin Alfa
  Drugs, 1995
• S7.7 The role of carbohydrate on the biological activity of erythropoietin
  Glycoconjugate Journal, 1993
• The role of carbohydrate in recombinant human erythropoietin
  European Journal of Biochemistry, 1990
• Expression cloning of the murine erythropoietin receptor
  Cell, 1989
• Site-specific glycosylation of human recombinant erythropoietin: analysis of glycopeptides or peptides at each glycosylation site by fast atom bombardment-mass spectrometry
  Biochemistry, 1988
• Comparative structural study of N-linked oligosaccharides of urinary and recombinant erythropoietins
  Biochemistry, 1988
• Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin
  New England Journal of Medicine, 1987
• EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSIS
  The Lancet, 1986
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
  Nature, 1970